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Abstract
Background: Electrochemotherapy treats tumors by combining specific chemotherapeutic drugs with an
intracellular target and electric pulses, which increases drug uptake into the tumor cells. Electrochemotherapy has
been successfully used for treatment of easily accessible superficial tumor nodules. In this paper, we present the
first case of deep-seated tumor electrochemotherapy based on numerical treatment planning.
Methods: The aim of our study was to treat a melanoma metastasis in the thigh of a patient. Treatment planning
for electrode positioning and electrical pulse parameters was performed for two different electrode configurations:
one with four and another with five long needle electrodes. During the procedure, the four electrode treatment
plan was adopted and the patient was treated accordingly by electrochemotherapy with bleomycin. The response
to treatment was clinically and radiographically evaluated. Due to a partial response of the treated tumor, the
metastasis was surgically removed after 2 months and pathological analysis was performed.
Results: A partial response of the tumor to electrochemotherapy was obtained. Histologically, the metastasis
showed partial necrosis due to electrochemotherapy, estimated to represent 40-50% of the tumor. Based on the
data obtained, we re-evaluated the electrical treatment parameters in order to correlate the treatment plan with
the clinical response. Electrode positions in the numerical model were updated according to the actual positions
during treatment. We compared the maximum value of the measured electric current with the current predicted
by the model and good agreement was obtained. Finally, tumor coverage with an electric field above the
reversible threshold was recalculated and determined to be approximately 94%. Therefore, according to the
calculations, a small volume of tumor cells remained viable after electrochemotherapy, and these were sufficient
for tumor regrowth.
Conclusions: In this, the first reported clinical case, deep-seated melanoma metastasis in the thigh of the patient
was treated by electrochemotherapy, according to a treatment plan obtained by numerical modeling and
optimization. Although only a partial response was obtained, the presented work demonstrates that treatment of
deep-seated tumor nodules by electrochemotherapy is feasible and sets the ground for numerical treatment
planning-based electrochemotherapy.
Trial registration: EudraCT:2008-008290-54
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Electrochemotherapy is a type of tumor treatment that
combines the use of specific chemotherapeutic drugs
which have an intracellular target and low membrane per-
meability, with application of electric pulses to the tumors
to increase drug uptake into cells. It provides good local
tumor control when the two modalities combined are
optimized; i.e. drug choice, distribution and concentration
in the tumors, in addition to adequate electric pulse para-
meter selection and pulse delivery leading to cell mem-
brane electroporation of the tumor tissue [1-4].
The drug used in electrochemotherapy needs to be
adequately distributed in the tumor and present at a suf-
ficient concentration. For treatment of small subcuta-
neous tumor nodules, such as melanoma metastases,
intratumoral bleomycin or cisplatin administration is
recommended, whereas for treatment of bigger tumor
nodules, intravenous injection of bleomycin is used.
Drug doses needed for treatment are provided in the
published Standard Operating Procedures [5]. For opti-
mal drug distribution within the tumor after intratu-
moral injection, only a few minutes are needed between
the drug injection and electroporation of tumors. After
intravenous bleomycin injection, at least 8 minutes are
needed for the drug to be in a pharmacological peak in
the tumor and the drug remains at a sufficient concen-
tration for at least another 20 minutes [6].
The second prerequisite for successful electroche-
motherapy is that the whole tumor mass is exposed to a
sufficiently high electric field. This can be achieved by
appropriate selection and placement of electrodes, and
application of electric pulses of adequate amplitude. The
distribution of the electric field after application of electric
pulses by plate or needle electrodes has already been
extensively elaborated for small tumor nodules [2]. These
settings and electrodes provide efficient treatment of
superficial tumor nodules up to 3 cm in diameter in a sin-
gle electrochemotherapy session and have even been used
to treat bone cancer [7-9]. However, to enable treatment
of deep-seated tumors, a design of long needle electrodes
and in particular their positioning with respect to the
tumor is needed. If solid tumors of 3-4 cm diameter are
located deep in the body, choosing electrical parameters
that would result in a good clinical response and that
would have no or minimal damage to normal tissue is of
the outmost importance, especially in cases where tumors
are located close to vital organs. Numerical modeling in
treatment planning is the proposed approach that also
allows verification of the electrical parameters based on
the clinical response to electrochemotherapy [10].
In order to also develop electrochemotherapy for
treatment of deep-seated tumors, the aim of our study
was to treat a deep-seated melanoma metastasis in the
thigh of a patient by custom-made long needle electro-
des. Based on treatment planning, the electric pulse
parameters and positioning of electrodes were deter-
mined. The patient was treated accordingly by electro-
chemotherapy with bleomycin. The response to
treatment was clinically, radiographically and histologi-
cally evaluated. Due to a partial response of the treated
tumor (reduction in size by more than 50%), the metas-
tasis was surgically removed after 2 months and patho-
logical analysis was performed. Based on the data
obtained, we re-evaluated the electrical treatment para-
meters in order to correlate the treatment plan with the
clinical response of the electrochemotherapy-treated
metastasis.
Materials and methods
Clinical data of the patient
A 51-year-old male Caucasian patient with a diagnosis
of melanoma had been previously treated by electroche-
motherapy with bleomycin given intravenously. The
treated small superficial metastases on the right leg
regressed completely after the treatment. In October
2008, a PET-CT was performed, which revealed a deep-
seated metastasis in the right thigh (Figure 1). In
December 2008, electrochemotherapy with long needle
electrodes was performed using bleomycin given intrave-
nously (15,000 IU/m
2) and electric pulses were delivered
10-12 minutes after injection. The study was approved
by the national Ethics committee and institutional
board. The patient signed an informed consent to parti-
cipate in the study. The positioning of the electrodes
Figure 1 Size of the melanoma metastasis determined by
ultrasound. The figure shows the tumor size shortly before the
treatment, at the time of the treatment itself and during the follow-
up. Regrowth of the tumor was observed at day 31 and the tumor
was excised at day 52.
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formed in general anesthesia; in order to avoid strong
muscle contractions induced by electric pulses the
myorelaxant vercuronium bromide (Norcuron, Organon)
was used. In February 2009, regrowth of the metastasis
was observed by ultrasound. The metastasis was surgi-
cally removed by the end of February and a pathological
analysis of the excised tissue was performed.
Numerical treatment planning
Based on the PET-CT radiographs, the position of the
melanoma metastasis was determined. Its size was 20 ×
14 mm in diameter and it was located in the right thigh,
20 mm under the skin. The location was estimated to
be on or minimally invasive into thigh muscle fascia.
During preparation for electrochemotherapy, a slight
growth of the metastasis was observed ultrasonographi-
cally (Figure 1). The anatomical model geometry used in
the treatment planning procedure was obtained from
CT images. All clinically relevant tissue structures
(tumor, muscle, adipose tissue) were delineated and
used to construct 3D geometry objects in the numerical
computing environment Matlab (Mathworks, USA) by
the planar contour method as previously described by
[11] (Figure 2). The geometry of objects was then
imported into the finite element analysis software Com-
sol Multiphysics 3.5 (COMSOL AB, Sweden). In the
model, all tissues were considered homogeneous, the
assigned conductivity values being: 0.2 S/m for the
tumor, 0.018 S/m for adipose tissue, 0.135 S/m and 0.75
S/m for muscle tissue perpendicular and parallel to the
muscle direction, respectively. These conductivity values
were considered as approximations for DC values, and
are extrapolated from measurements performed at
10 Hz. During the delivery of electric pulses, the
conductivity of tissues changes as a consequence of elec-
troporation. Measurements of conductivity during pulse
application have shown that conductivity changes by a
factor of around 3.5; therefore conductivity of electropo-
rated tissue was increased by this factor, which agrees
well with measurements taken on rat muscle and liver
tissue and with the post-electroporation conductivity
estimation performed by mathematical modeling for
rabbit liver [12,13]. All conductivity values were chosen
according to previous measurements of tumor and tis-
sue conductivity and models of subcutaneous tumor and
skin electroporation [12-14].
Numerical calculations were performed with Comsol.
Electric field distribution in the tissue, caused by an
electroporative pulse, was determined by solving the
Laplace equation for static electric currents:
   () 0
where s and  a r et i s s u ee l e c t r i cc o n d u c t i v i t ya n d
electric potential, respectively. The boundary conditions
used in our calculations were a constant potential on
the surface of the electrodes and electrical insulation on
all outer boundaries of the model. For tumors, the
reversible electroporation threshold was considered to
be 400 V/cm, for adipose tissue 100 V/cm, for muscle
tissue 200 V/cm and 80 V/cm, in the perpendicular
direction to muscle fibers and in the parallel direction,
respectively. The irreversible threshold was set to 900
V/cm for all tissues.
In treatment planning, a numerical model of electro-
poration was used that did not take into account
changes in tissue conductivity during electroporation.
After the treatment, in order to compare the measured
electric currents during electric pulse delivery and the
currents predicted by the model, a model that took into
account the changes in tissue conductivity was used.
The conductivity dependencies on the electric field s(E)
of all tissues were approximated by a step function [14].
Electrode positions and voltages to be applied between
individual electrodes were optimized using a genetic
algorithm, described in more detail in previous studies
[15,16]. In short, the algorithm optimized the position of
each electrode (x, y, z) - in discrete steps of 1 mm and
the voltage between each pair of electrodes in discrete
steps of 100 V. Feasible ranges of all these parameters
were taken into account, as well as the specifications of
t h ee l e c t r i cp u l s eg e n e r a t o r( see below). First, a popula-
tion of treatment plans (consisting of all electrode
Figure 2 Anatomical model consisting of adipose tissue (pink),
muscle tissue (blue), melanoma metastasis (green) and
inserted electrodes. Note that only the closest two muscles were
considered in the model, as the other muscle groups lying further
away would not contribute to the model accuracy and would only
increase the computational cost.
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The treatment plans then evolved over several hundred
generations by mathematical operations cross-over and
mutation according to the fitness function:
FV V Trev Hirrev    100 10
where F is fitness, VTrev is the tumor volume subjected
to the local electric field above the reversible threshold
and VHirrev is the volume of healthy tissue subjected to a
local electric field above the irreversible threshold. The
weights in the fitness function were chosen to reflect the
importance of the individual parameters for efficient ECT.
Namely, VTrev is crucial for efficient ECT; therefore its
weight is larger (100) than the weight of VHirrev. The algo-
rithm was stopped after 500 iterations - this number of
iterations gave good solutions in previous studies [15,16]
and the quality of the treatment plan was compared to
previously set treatment plan requirements - when a suffi-
ciently high quality treatment plan was achieved, i.e.t h e
whole tumor was covered with a sufficiently high electric
field and very little of the surrounding tissue was affected
by the field. The optimization took 5 h on a Windows XP,
3.0 GHz, 2 GB RAM desktop computer.
Electrodes, pulse generator and pulse parameters
Four custom-made electrodes made of stainless steel, 1.8
mm in diameter with sharpened tips, insulated except
for the upper 4 cm, were used. An additional 1.2 mm in
diameter electrode was considered for direct insertion
into the center of the tumor. The electrodes were con-
nected to independently controlled generator outputs of
the Cliniporator Vitae (IGEA, Carpi, Italy). The Clini-
porator Vitae device is a pulse generator with 6 inde-
pendently controlled and electrically insulated outputs
each providing up to 3000 V, max current 50 A, deliver-
ing 8 rectangular electrical pulses (rise time 1 μs) of 100
μs duration at a pulse repetition frequency of 4 Hz [17].
The current and voltage are measured and logged with
a precision better than 3%, which allows for pulse deliv-
ery control and post-treatment evaluation. Pulses were
delivered 10-12 minutes after i.v. bolus injection of
bleomycin.
Results
Optimized treatment plan
Treatment planning was performed for two different
electrode configurations. The first configuration was with
five electrodes with a central electrode inserted in the
tumor and four electrodes distributed around the tumor,
while the second configuration was with four electrodes
outside the tumor (Figure 3). Although the five-electrode
o p t i o nw a sr e c o g n i z e da ss u p e r i o ra n dw a st h ep r i m a r y
choice for treatment, the central electrode could not be
inserted into the tumor as the tumor was very mobile,
effectively “floating” in the surrounding adipose tissue.
This mobility of the tumor also made it very difficult to
rigorously follow the treatmen tp l a nf o rf o u re l e c t r o d e s ,
and as a result the electrodes were positioned farther
away from the tumor than originally planned.
The results of optimization were electrode positions
and minimum voltages for each electrode pair. Electrode
positions outside the tumor were similar in both config-
urations, i.e. very close to the tumor surface; however
the fifth electrode inside the tumor significantly reduced
the required voltage to achieve efficient membrane elec-
troporation of cells in the whole tumor, thereby also
reducing damage to healthy tissue. The maximum vol-
tages required were 3000 V and 2500 V in the four and
five electrode configuration, respectively. The volume of
irreversibly permeabilized healthy tissue according to
the treatment plan was 13.8 cm
3 ( o ft h a t1 1 . 5c m
3 adi-
pose tissue and 2.33 cm
3 muscle tissue) in the four elec-
trode configuration and 12.3 cm
3 (of that 10.4 cm
3
a d i p o s et i s s u ea n d1 . 8 8c m
3 muscle tissue) in the five
electrode configuration. Depth of insertion was a few
millimeters deeper than the tumor, slightly penetrating
the muscle tissue.
Treatment and response to the treatment
During the procedure, the four-electrode treatment plan
was adopted. The electrodes were placed according to
the treatment plan as depicted in Figure 4. Electrodes
Figure 3 Electrode positions according to the treatment plan.
Electrode positions for four (dashed line circles) and five (solid line
circles) electrodes are shown. The presented tumor cross-section is
a parallel projection of the tumor on a plane parallel to the skin
surface. Note that electrode 2 is in the same location in both
treatment plans.
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four outer corners of the tumor in the fat tissue, the
deepest location being minimally inserted into the mus-
cle (Figure 4). Eight pulses of 100 μs each were delivered
between each pair of electrodes. In total, 6 times 8
pulses were delivered to the tumor with amplitudes of
2800 V between electrodes (pair 1-2) 25 mm apart,
2500 V between electrodes (1-3, 2-4 and 3-4) 20 mm
apart, and 3000 V between diagonal electrodes (1-4 and
2-3) (Figure 5). The currents recorded during electric
pulse delivery were between 9 and 19 A.
The treatment was performed in general anesthesia and
due to the myorelaxant given to the patient, only minor
muscle contractions were observed. No other side-effects
were noticed. The patient reported no discomfort after the
treatment, and left the hospital after 2 days. The response
to treatment with electrochemotherapy was followed ultra-
sonographically at regular time intervals (Figure 1). The
first post-operative ultrasound showed a substantial
decrease in the tumor volume (more than 50%), while the
second showed a regrowth of tumor tissue.
In February 2009, i.e. 52 days after electrochemother-
apy was performed, the metastasis was excised. It was
located 2 cm under the skin in the deep subcutaneous
f a tt i s s u e ,a b u t t i n go nt h em u s c l ef a s c i a .T h es i z eo f
the metastasis measured after excision (22 × 15 mm)
was determined on the pathological cross-section
(Figure 6).
Histologically, the metastasis showed partial necrosis,
estimated to represent 40-50% of the tumor. It was not
possible to discriminate between spontaneous and
induced necrosis. However, there was indirect evidence
of the effect of electrochemotherapy; i.e. the presence of
fat necrosis and obliterated blood vessels in the tissue
a r o u n dt h et u m o r( F i g u r e7 ) .T h e s eo b s e r v a t i o n sw o u l d
not be expected in a fast-growing, untreated metastasis.
Numerical model validation
After the treatment, the geometry of the numerical
model was updated according to measurements taken
during the operating procedure and photo documenta-
tion of the treatment. Specifically, the four electrode
positions in the model were changed according to these
Figure 4 Actual positioning of the electrodes relative to the
treatment plan. Electrode positions according to the treatment
plan (dashed line circles) and actual electrode positions during
treatment as determined by ultrasonography and photo
documentation (solid line circles). The presented tumor cross-
section is a parallel projection of the tumor on a plane parallel to
the skin surface.
Figure 5 Combinations of electric pulse delivery between the
electrodes as well as voltages between each pair.
Figure 6 Cross-section of the excised melanoma metastasis
(in toto).
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value of the electric current measured by the Clinipora-
tor Vitae during electric pulse delivery with the current
predicted by the numerical model. Good agreement was
obtained between the measurements and calculations, as
presented in Table 1. Finally, tumor coverage with an
electric field above the reversible threshold was recalcu-
lated using the revised geometry and the volume of the
reversibly permeabilized tumor was determined to be
approximately 94% (Figure 8).
Discussion
We present here the first study of deep-seated tumor
electrochemotherapy based on numerical treatment plan-
ning. Namely, electrochemotherapy was, until now only
used for superficial and accessible tumor nodules, with
an approximately 80% objective response rate [1,7,18-22].
In this, the first reported clinical case, a deep-seated mel-
anoma metastasis in the thigh of the patient was treated
by insertion of long needle electrodes around the tumor.
A new electric pulse generator was used that provides
higher voltages and currents and has six independently
controlled insulated outputs, which thus allow for treat-
ment of deeper-seated tumors by delivering electric
pulses between different pairs of electrodes.
The electric conductivity values taken into account
in the numerical model have been obtained from measure-
ments done mostly on large animal tissues, which are not
necessarily valid for human tissue as well [13]. Further-
more, these values are not valid for electroporated tissue,
as electroporation increases tissue conductivity. In one of
our previous studies, we measured the conductivity of rat
muscle and liver tissue and the conductivity increased
between 3.2-3.8 times for both tissue types [12]. Also,
Figure 7 Histology of melanoma metastasis treated by electrochemotherapy. The tumor (A) shows partial necrosis (short arrows). In the
surrounding tissue (B), fat necrosis (long arrow) and obliterated blood vessels (double arrow) are visible (H&E, original magnification 20×).
Table 1 Agreement between maximum measured
electrical currents and currents calculated in the
numerical model
Electrode
pair
Measured current
[A]
Calculated current
[A]
Error
[%]
1-2 16 16.2 1
1-3 18 17.3 -4
1-4 10 9.5 -5
2-3 19 17.2 -9
2-4 9 8.4 -7
3-4 9 8.0 -11
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for rabbit liver resulted in an estimated conductivity
increase of 3.6 [11]. In this study, an increase in conductiv-
ity of 3.5 as a result of electroporation was used for all tis-
sues, a choice which seems to be at least partly validated
by the agreement between the measured and calculated
electric current in our study (Table 1).
In our post-treatment model, tissue electroporation
thresholds for muscle and tumor were taken from pre-
vious studies in which these thresholds were determined
by comparing in vivo measurements and numerical
modeling of electroporation of different tissues
[14,23,24]. In all these studies, the assumption was made
that the values of the electric field, at which a change in
tissue properties occur, coincides with the electropora-
tion thresholds. This assumption was already considered
both theoretically and practically in previous studies and
can be considered as justified [25-27].
Two different electroporation models were used in our
present study; the first which took into account changes
in tissue properties and the second which did not, a
simplification that made the calculation much faster.
Both models predicted similar electroporation volumes
(results not shown), while only the first model could
predict the electric current density. As such, the second
model was used for optimization-based treatment
planning and the first one for validation by comparing
the measured and calculated electric currents.
According to the model used after the treatment, inac-
curacies in positioning of the electrodes are most likely
responsible for the inadequate electroporation of the
entire tumor volume, although possible deviation from
the assigned electrical conductivities and/or deviations
from the assigned electroporation threshold for the tis-
sues cannot be disregarded. Nevertheless, good agree-
ment between the predicted and the measured delivered
currents implies that the conductivity values chosen
were very close to the real values. Under the assumption
that the positioning of the electrodes was responsible for
the inadequate tumor electroporation, calculations show
that only a small percent of the tumor was not success-
fully electroporated (app. 6%); however this was enough
for the tumor to survive and start growing again. While
normally these relatively small errors in electrode posi-
tioning (Figure 4) would not lead to an unsuccessful
treatment, the proximity of three different tissues with
very different conductivities made the treatment very
sensitive to electrode positioning. Adipose tissue that
surrounded the tumor had by far the lowest conductiv-
ity, which meant that according to the voltage divider
principle the electric field was largest in the adipose tis-
sue around the tumor and not in the tumor [28].
Conclusions
Electrochemotherapy of a deep-seated tumor was per-
formed in a patient with the aim to verify the treatment
approach, and the use of treatment planning in optimiz-
ing the positioning of the electrodes and electrical para-
meters. Although the configuration of five electrodes
was recognized as the best in treatment planning, it was
not possible to execute it due to “floating” of the tumor
in the adipose tissue. The four-electrode position was
thus used and at follow-up of the tumor growth, signifi-
cant tumor reduction was observed (Figure 1). For effec-
tive treatment, however, all viable tumor cells have to be
destroyed in order to prevent tumor regrowth. There-
fore, as calculated in this tumor model, even a small
percentage of remaining viable tumor tissue (6%) after
electrochemotherapy was enough for tumor regrowth.
Nevertheless, this clinical case demonstrates that treat-
ment of deep-seated tumor nodules by electroche-
motherapy is feasible and that optimization of the
treatment approach by tumor numerical modeling is of
significant help.
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